MeritValue

Cannabis Bioscience International Holdings, Inc.

CBIHdata completeness 88%3 fiscal years on file

Data notes: no data for concept 'capex'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'depreciationAmortization'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'interestExpense'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2023FY 2024FY 2025
Revenue$316,8251$248,8412$303,0222
Net income−$1.03M3−$651,3454−$548,8204
Operating cash flow−$898,3675−$479,3826−$329,6276
Capital expenditure———
Free cash flow (derived)———
Total debt$528,1847$512,8308$550,2798
Cash & equivalents$8,9139$7559$12,9529
Diluted shares9.00B10.32B10.72B

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0
your share of equity
Profit it earned you last year
−$0
Free cash flow it threw off
—
Debt you’d be carrying
$0

10 shares is a claim on −$0 of net worth that earned you −$0 last year, against $0 of debt.

iii. Is this a good business?
Moat signal · return on equity
— avg · 3y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+19% shares · 3y

Share count is up 19% over 3 years — owners have been diluted. Worth asking what they got for it. Total debt has held roughly steady.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2023-05-31 · accession 0001683168-24-006402 (Revenues)
  2. 10-K · period ending 2024-05-31 · accession 0001683168-25-007174 (Revenues)
  3. 10-K · period ending 2023-05-31 · accession 0001683168-24-006402 (NetIncomeLoss)
  4. 10-K · period ending 2024-05-31 · accession 0001683168-25-007174 (NetIncomeLoss)
  5. 10-K · period ending 2023-05-31 · accession 0001683168-24-006402 (NetCashProvidedByUsedInOperatingActivities)
  6. 10-K · period ending 2024-05-31 · accession 0001683168-25-007174 (NetCashProvidedByUsedInOperatingActivities)
  7. 10-K · period ending 2023-05-31 · accession 0001683168-24-006402 (LongTermDebtNoncurrent)
  8. 10-K · period ending 2024-05-31 · accession 0001683168-25-007174 (LongTermDebtNoncurrent)
  9. 10-K · period ending 2023-05-31 · accession 0001683168-25-007174 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)